Ftse Mib
33.186,06
0,84%
DAX
18.105,44
0,18%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
65.710,27
-1,17%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Xilio Therapeutics Inc (XLO) Xilio Therapeutics Inc (XLO) Notizie

Xilio Therapeutics Inc

XLO
0,95
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:34:50
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:06EDGAR2Form 8-K - Current report
13/6/202422:15EDGAR2Form 8-K - Current report
13/6/202422:05GLOBEXilio Therapeutics Appoints Aoife Brennan, M.D., and James..
14/5/202414:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:45EDGAR2Form 8-K - Current report
14/5/202413:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
07/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
01/4/202422:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
28/3/202412:05GLOBEXilio Therapeutics Announces $11.3 Million Private Placement..
28/3/202412:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
28/2/202422:01GLOBEXilio Therapeutics to Participate in Novel Immuno-Oncology..
31/1/202422:01GLOBEXilio Therapeutics to Present at Guggenheim 6th Annual..
19/1/202422:30EDGAR2Form 8-K - Current report
08/1/202413:30GLOBEXilio Therapeutics Highlights Recent Advances Across..
03/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:05EDGAR2Form 8-K - Current report
07/12/202313:45EDGAR2Form 8-K - Current report
07/12/202313:30GLOBEXilio Therapeutics Announces Initiation of Enrollment for..
09/11/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:13EDGAR2Form 8-K - Current report
09/11/202322:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
09/11/202322:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
09/11/202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
09/11/202322:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
03/11/202321:05EDGAR2Form 8-K - Current report
03/11/202317:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
31/10/202314:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
27/9/202323:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
07/9/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/9/202314:35EDGAR2Form 8-K - Current report
05/9/202314:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
05/9/202313:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
19/8/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:40EDGAR2Form 8-K - Current report
14/8/202313:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
07/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202322:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/8/202322:15EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
Apertura: Min: Max:
Chiusura: 0,95

La tua Cronologia

NASDAQ
XLO
Xilio Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network